DENOSUMAB IN PATIENTS WITH CHRONIC KIDNEY DISEASE

被引:0
|
作者
Monov, Simeon [1 ]
Monova, Daniela [2 ]
Shumnalieva, Russka [1 ]
Stambolova, Maria [2 ]
机构
[1] Med Univ Sofia, Sofia, Bulgaria
[2] Med Univ Sofia, Inst Med, Sofia, Bulgaria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
43
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [21] Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative
    Tharsan Kanagalingam
    Tayyab Khan
    Nabil Sultan
    Andrea Cowan
    Jenny Thain
    Cindy Hoy
    Seadna Ledger
    Kristin K Clemens
    Archives of Osteoporosis, 18
  • [22] The relationship between chronic kidney disease and denosumab-induced hypocalcemia in high-age osteoporotic patients
    Horikawa, Akira
    Hongo, Michio
    Kasukawa, Yuji
    Shimada, Yoichi
    Kodama, Hiroyuki
    Sano, Akihisa
    Miyakoshi, Naohisa
    JOURNAL OF BONE AND MINERAL METABOLISM, 2022, 40 (04) : 670 - 676
  • [23] The relationship between chronic kidney disease and denosumab-induced hypocalcemia in high-age osteoporotic patients
    Akira Horikawa
    Michio Hongo
    Yuji Kasukawa
    Yoichi Shimada
    Hiroyuki Kodama
    Akihisa Sano
    Naohisa Miyakoshi
    Journal of Bone and Mineral Metabolism, 2022, 40 : 670 - 676
  • [24] Patients with Chronic Kidney Disease
    Kalamas, Alicia Gruber
    Niemann, Claus U.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (06) : 1109 - +
  • [25] Effects of denosumab treatment in chronic liver disease patients with osteoporosis
    Chisato Saeki
    Mitsuru Saito
    Tsunekazu Oikawa
    Masanori Nakano
    Yuichi Torisu
    Masayuki Saruta
    Akihito Tsubota
    World Journal of Gastroenterology, 2020, 26 (33) : 4960 - 4971
  • [26] Effects of denosumab treatment in chronic liver disease patients with osteoporosis
    Saeki, Chisato
    Saito, Mitsuru
    Oikawa, Tsunekazu
    Nakano, Masanori
    Torisu, Yuichi
    Saruta, Masayuki
    Tsubota, Akihito
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (33) : 4960 - 4971
  • [27] Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease
    Wu, Ping-Hsun
    Lin, Ming-Yen
    Huang, Teng-Hui
    Lee, Tien-Ching
    Lin, Sung-Yen
    Chen, Chung-Hwan
    Kuo, Mei-Chuan
    Chiu, Yi-Wen
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [28] Extreme Hypocalcaemia and Hyperparathyroidism following Denosumab. Is this drug safe in chronic kidney disease?
    Sirvent, Ana E.
    Enriquez, Ricardo
    Sanchez, Maria
    Gonzalez, Cesar
    Millan, Isabel
    Amoros, Francisco
    NEFROLOGIA, 2014, 34 (04): : 542 - 544
  • [29] Can lumbar spine bone mineral density predict readmission in denosumab-treated patients with chronic kidney disease?
    Cheng, Ben-Chung
    Chen, Ying-Chou
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 53 - 56
  • [30] Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?
    Chen, Ying-Chou, Sr.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68